CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

✍ Scribed by Hu, S.; Xu-Monette, Z. Y.; Balasubramanyam, A.; Manyam, G. C.; Visco, C.; Tzankov, A.; Liu, W.-m.; Miranda, R. N.; Zhang, L.; Montes-Moreno, S.; Dybkaer, K.; Chiu, A.; Orazi, A.; Zu, Y.; Bhagat, G.; Richards, K. L.; Hsi, E. D.; Choi, W. W. L.; Han van Krieken, J.; Huang, Q.; Huh, J.; Ai, W.; Ponzoni, M.; Ferreri, A. J. M.; Zhao, X.; Winter, J. N.; Zhang, M.; Li, L.; Moller, M. B.; Piris, M. A.; Li, Y.; Go, R. S.; Wu, L.; Medeiros, L. J.; Young, K. H.

• Book ID: 119975534
• Publisher: American Society of Hematology
• Year: 2013
• Tongue: English
• Weight: 888 KB
• Volume: 121
• Category: Article
• ISSN: 0006-4971
• DOI: 10.1182/blood-2012-10-461848